ArrowMark Colorado Holdings’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-196,936
Closed -$10.3M 316
2026
Q1
$10.3M Sell
196,936
-30,507
-13% -$1.83M 0.27% 114
2025
Q4
$13.4M Sell
227,443
-108,571
-32% -$6.6M 0.29% 100
2025
Q3
$18.7M Sell
336,014
-330,591
-50% -$17.7M 0.35% 79
2025
Q2
$34.3M Buy
666,605
+30,767
+5% +$1.55M 0.62% 57
2025
Q1
$37.3M Sell
635,838
-68,787
-10% -$4.66M 0.6% 58
2024
Q4
$50.8M Sell
704,625
-3,895
-0.5% -$286K 0.68% 47
2024
Q3
$56.6M Sell
708,520
-521,491
-42% -$39.2M 0.73% 42
2024
Q2
$88.1M Sell
1,230,011
-14,449
-1% -$1.06M 1.05% 28
2024
Q1
$87.6M Buy
1,244,460
+61,386
+5% +$4.39M 0.98% 31
2023
Q4
$91.3M Buy
1,183,074
+168,915
+17% +$11.1M 1.01% 32
2023
Q3
$69M Buy
1,014,159
+116,147
+13% +$9.18M 0.84% 36
2023
Q2
$73.3M Buy
898,012
+145,569
+19% +$11.7M 0.8% 41
2023
Q1
$55.8M Buy
752,443
+228,516
+44% +$17.6M 0.63% 49
2022
Q4
$43.4M Buy
+523,927
New +$41.6M 0.52% 60

Other funds holding TECH

ArrowMark Colorado Holdings's TECH Position: Q2 2026 in Review

ArrowMark Colorado Holdings sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 196,936 shares — an estimated $10.3M sold.

ArrowMark Colorado Holdings first reported a position in TECH in Q4 2022 and held it in 14 quarters. The position peaked at $91.3M in Q4 2023. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • ArrowMark Colorado Holdings reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 196,936 Bio-Techne shares in Q2 2026, an estimated $10.3M.
  • ArrowMark Colorado Holdings first reported a position in Bio-Techne in Q4 2022 and held it in 14 quarters.
  • ArrowMark Colorado Holdings's Bio-Techne position peaked at $91.3M in Q4 2023.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.